Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, Inc. Second Quarter 2025 Financial Results and Business Update Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | OrbiMed Advisors Samuel Isaly | 605,531 | $896,186 | 0.02% | |
2. | Adage Capital Management Phill Gross And Robert Atchinson | 330,000 | $488,400 | 0% | |
3. | Vestal Point Capital Ryan Wilder | 149,800 | $221,704 | -15% | 0.01% |
4. | Alyeska Investment Group Anand Parekh | 52,630 | $77,892 | 0% | |
5. | Ikarian Capital Neil Shahrestani | 28,493 | $42,170 | 0.01% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.67 | 1,500 | $2,505.00 | 24,514 | 2022-01-28 | Filing | |
$2.02 | 1,500 | $3,030.00 | 23,014 | 2022-01-21 | Filing | |
$2.20 | 1,500 | $3,300.00 | 21,514 | 2022-01-14 | Filing | |
$2.39 | 1,500 | $3,585.00 | 20,014 | 2022-01-07 | Filing | |
$3.16 | 1,000 | $3,160.00 | 18,514 | 2021-11-19 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.27 | 527,863 | $143,948.24 | 16,683 | 2020-08-27 | Filing | |
$0.27 | 1,876 | $510.08 | 0 | 2020-08-27 | Filing | |
$0.27 | 182,492 | $49,619.57 | 21,919 | 2020-08-27 | Filing | |
$1.19 | 16,700 | $19,873.00 | 616,389 | 2019-09-24 | Filing | |
$0.00 | 0 | $0.00 | 816,702 | 2019-09-23 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 35,725 | $52,874 | 0% | |
2. | 17,169 | $25,410 | 0% | |
3. | 16,063 | $23,773 | 0% | |
4. | 13,173 | $19,496 | 0% | |
5. | 9,956 | $14,735 | 0% |